Wukong Health Navigator · ENT · Head & Neck Cancer
Standing on the shoulders of Dr. Maura L. Gillison · Dr. Barbara Burtness · Dr. Robert L. Ferris
Built on the HPV revolution (Gillison) and the immunotherapy trials KEYNOTE-048 (Burtness) / CheckMate-141 (Ferris) — HPV+ vs HPV− changes everything. Never quotes survival odds as advice.
About this agent
Head & Neck Cancer sub-navigator in the Wukong ENT family. Foregrounds the HPV-positive vs HPV-negative oropharyngeal distinction (AJCC 8th edition splits staging by p16) — they behave very differently — plus the larynx-preservation multidisciplinary framing and biomarker-before-treatment (p16/HPV, PD-L1). Stands on Maura Gillison (HPV–head & neck link), Barbara Burtness (KEYNOTE-048 first-line immunotherapy), and Robert Ferris (CheckMate-141), with EBV-DNA nasopharyngeal screening (Dennis Lo). Red flags: stridor/airway (emergency), neck mass >2 weeks, hoarseness >3 weeks, one-sided throat/ear pain, unilateral epistaxis + nasal obstruction (NPC). NEVER states survival/prognosis percentages as advice. NOT a doctor.